SYNDAX PHARMACEUTICALS INC's ticker is SNDX and the CUSIP is 87164F105. A total of 101 filers reported holding SYNDAX PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 1.24 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $3,147,475 | +16.5% | 153,311 | +35.0% | 0.00% | 0.0% |
| Q1 2024 | $2,701,966 | +16.8% | 113,528 | +6.0% | 0.00% | 0.0% |
| Q4 2023 | $2,313,696 | +6.1% | 107,066 | -28.7% | 0.00% | 0.0% |
| Q3 2023 | $2,179,902 | +150.5% | 150,131 | +261.0% | 0.00% | – |
| Q2 2023 | $870,374 | -35.0% | 41,585 | -34.4% | 0.00% | -100.0% |
| Q1 2023 | $1,338,733 | +181.9% | 63,387 | +239.7% | 0.00% | – |
| Q4 2022 | $474,898 | -0.4% | 18,660 | -14.3% | 0.00% | – |
| Q4 2021 | $477,000 | +12.2% | 21,778 | +14.4% | 0.00% | – |
| Q1 2021 | $425,000 | -63.8% | 19,033 | -64.0% | 0.00% | -100.0% |
| Q4 2020 | $1,175,000 | +7.4% | 52,846 | -28.5% | 0.00% | – |
| Q2 2020 | $1,094,000 | – | 73,875 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 2,168,691 | $30,297,000 | 13.16% |
| Boxer Capital, LLC | 234,220 | $3,272,000 | 0.78% |
| SPHERA FUNDS MANAGEMENT LTD. | 296,310 | $4,139,000 | 0.70% |
| Ghost Tree Capital, LLC | 200,000 | $2,794,000 | 0.58% |
| Eventide Asset Management | 225,000 | $3,143,000 | 0.20% |
| Vident Investment Advisory, LLC | 103,558 | $1,447,000 | 0.12% |
| J. Goldman & Co LP | 147,181 | $2,056,000 | 0.11% |
| TIVERTON ASSET MANAGEMENT LLC | 137,732 | $1,924,000 | 0.10% |
| Crestline Management, LP | 55,368 | $773,000 | 0.10% |
| Tekla Capital Management LLC | 200,000 | $2,794,000 | 0.10% |